3H (Suzhou) Pharmaceuticals Co., Ltd.
3H (Suzhou) Pharmaceuticals Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations | Solid Tumors With FGFR2 Alterations, Adult | Recruiting | Phase 1 / Phase 2 | 2026-01-27 | NCT06378593 | |
| A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations | Solid Tumors With FGFR2 Alterations, Adult | Not yet recruiting | Phase 1 | 2026-01-27 | NCT06287918 |